Skip to content

iRadimed IRMD Disposables — Total Revenue

Other product segments

MRI Compatible IV Infusion Pumps
$7.66M+27.8%
MRI Compatible Patient Vital Signs Monitoring Systems
$7.11M+8.6%
Services and other
$1.04M
Amortization of extended maintenance agreements
$659K
Ferro Magnetic Detection Systems
$621K+48.6%

Similar metrics at other companies

STERIS logo
STEConsumables — Revenue
$456.2M+6.4%
Omnicell logo
OMCLConsumables — Total revenues
$26.14M+4.2%
Illumina logo
ILMNConsumables — Total Revenue
$797M+3.8%
10x Genomics, Inc. logo
TXGConsumables — Revenue
$129.8M+12.5%
Bausch + Lomb logo
BLCODevices — Total revenues
$480M+7.1%
Intuitive Surgical logo
ISRGInstruments and accessories — Total Revenue
$1.69B+23.3%

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's disposables — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's disposables — total revenue?
iRadimed (IRMD) reported disposables — total revenue of $4.89M in Q1 2026.
What does disposables — total revenue mean?
This metric represents the total revenue generated from the sale of single-use, consumable products designed for use with the company's specialized medical equipment. It serves as a key indicator of the recurring revenue stream derived from the installed base of hardware systems. Growth in this segment typically reflects higher utilization rates of the company's medical devices within clinical settings.